Tonghua Dongbao Pharmaceutical Co Ltd (600867) — Cash Flow Reinvestment Rate
Tonghua Dongbao Pharmaceutical Co Ltd (600867) has a Cash Flow Reinvestment Rate of 2.39x as of September 2025, reinvesting CN¥150.58 Million (capex CN¥150.58 Million ) from operating cash flow of CN¥62.99 Million. Check Tonghua Dongbao Pharmaceutical Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Tonghua Dongbao Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2000–2025)
Historical reinvestment intensity for Tonghua Dongbao Pharmaceutical Co Ltd across 25 annual periods. Explore 600867 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Tonghua Dongbao Pharmaceutical Co Ltd (2000–2025)
Year-by-year capital reinvestment analysis for Tonghua Dongbao Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 600867 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.64x | CN¥1.82 Billion | CN¥689.23 Million | CN¥517.69 Million | ▲ +91.0% |
| 2024 | 1.38x | CN¥635.44 Million | CN¥459.74 Million | CN¥568.73 Million | ▲ +63.3% |
| 2023 | 0.85x | CN¥729.22 Million | CN¥861.52 Million | CN¥348.13 Million | ▼ -44.2% |
| 2022 | 1.52x | CN¥1.31 Billion | CN¥863.09 Million | CN¥491.63 Million | ▲ +50.2% |
| 2021 | 1.01x | CN¥1.15 Billion | CN¥1.13 Billion | CN¥600.75 Million | ▲ +91.2% |
| 2020 | 0.53x | CN¥629.59 Million | CN¥1.19 Billion | CN¥479.59 Million | ▲ +46.2% |
| 2019 | 0.36x | CN¥416.13 Million | CN¥1.15 Billion | CN¥293.13 Million | ▼ -59.6% |
| 2018 | 0.89x | CN¥784.07 Million | CN¥876.94 Million | CN¥773.07 Million | ▲ +255.9% |
| 2017 | 0.25x | CN¥241.50 Million | CN¥961.19 Million | CN¥185.50 Million | ▼ -85.4% |
| 2016 | 1.72x | CN¥1.25 Billion | CN¥725.76 Million | CN¥411.53 Million | ▼ -12.1% |
| 2015 | 1.96x | CN¥576.63 Million | CN¥294.58 Million | CN¥400.09 Million | ▲ +279.9% |
| 2014 | 0.52x | CN¥106.08 Million | CN¥205.89 Million | CN¥106.08 Million | ▼ -40.2% |
| 2013 | 0.86x | CN¥190.36 Million | CN¥221.06 Million | CN¥190.36 Million | ▼ -30.8% |
| 2012 | 1.24x | CN¥241.83 Million | CN¥194.32 Million | CN¥241.83 Million | ▲ +174.7% |
| 2010 | 0.45x | CN¥72.66 Million | CN¥160.40 Million | CN¥72.66 Million | ▼ -4.8% |
| 2009 | 0.48x | CN¥79.07 Million | CN¥166.20 Million | CN¥79.07 Million | ▼ -22.5% |
| 2008 | 0.61x | CN¥56.67 Million | CN¥92.31 Million | CN¥56.67 Million | ▼ -71.3% |
| 2007 | 2.14x | CN¥258.34 Million | CN¥120.94 Million | CN¥258.34 Million | ▲ +17.6% |
| 2006 | 1.82x | CN¥286.90 Million | CN¥158.00 Million | CN¥286.90 Million | ▲ +40.3% |
| 2005 | 1.29x | CN¥119.38 Million | CN¥92.23 Million | CN¥119.38 Million | ▼ -65.3% |
| 2004 | 3.73x | CN¥49.08 Million | CN¥13.17 Million | CN¥49.08 Million | ▲ +193.0% |
| 2003 | 1.27x | CN¥57.90 Million | CN¥45.51 Million | CN¥57.90 Million | ▼ -54.5% |
| 2002 | 2.79x | CN¥89.41 Million | CN¥31.99 Million | CN¥89.41 Million | ▲ +270.9% |
| 2001 | 0.75x | CN¥88.69 Million | CN¥117.73 Million | CN¥88.69 Million | ▼ -58.2% |
| 2000 | 1.80x | CN¥52.46 Million | CN¥29.12 Million | CN¥52.46 Million | — |